Uebelhart, B <br/><br/>
Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  09 2017 
 - 2701-2705 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-017-4080-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biomarkers--blood<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Remodeling--drug effects<br/>Collagen Type I--blood<br/>Denosumab--administration & dosage<br/>Deprescriptions<br/>Diphosphonates--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Osteoporosis--blood<br/>Peptides--blood<br/>Retrospective Studies<br/>Withholding Treatment